Project Search Results


Research Categorization


Project Details


Contact Researcher and Awardee Organization


Funding Organization

Displaying 1 - 10 of 11 Projects
Project # Contact PI Funding Organization Fiscal Year
A single-center, randomized, placebo-controlled single & multiple ascending dose study in healthy subjects to study the safety, tolerability, food effect, pharmacokinetics and target engagement of the second-generation O-GlcNAcase inhibitor ASN121151
ADDF-1 Beher, Dirk Alzheimer's Drug Discovery Foundation 2020
Selective Cyclophilin D inhibitors for neurodegeneration
GC-2013179 Peel, Michael Alzheimer's Drug Discovery Foundation 2016
New experimental model development to test procognitive and neuroprotective compounds
EUJPND-NKFIH-Fülöp-797 Fülöp, Lívia National Innovation Office - Hungary 2016
The validation of new pharmacological strategies in schizophrenia and dementia models
EUJPND-NKFIH-Hernádi-798 Hernádi, István National Innovation Office - Hungary 2016
Development of new pharmaceutical drugs to treat dementia
EUJPND-NKFIH-Lendvai-803 Lendvai, Balázs National Innovation Office - Hungary 2016
The TRPA1 receptor, as potential target in neurodegenerative and inflammatory diseases, and cognitive disorders
EUJPND-NKFIH-Pintér-806 Pintér, Erika National Innovation Office - Hungary 2016
The mechanism of binding of drug candidates to disordered proteins
EUJPND-NKFIH-Tóth-809 Tóth, Gergely National Innovation Office - Hungary 2016
Dissecting the neuroprotective role of neurosteroids in Alzheimer’s disease: Modulation of bioenergetics and amyloid-ß/tau toxicity
EUJPND-SwissNSF-Anne-1575 Anne, Eckert Swiss National Science Foundation 2016
The factor XII-driven contact system as a new therapeutic target in Alzheimer's disease
EUJPND-SF|ARS-Klohs-1594 Klohs, Jan Synapsis Foundation|Alzheimer Research Switzerland 2016
O-GlcNAcase Inhibitors for Alzheimer's disease and Tauopathies
2013120-Beher-2013 Beher, Dirk Alzheimer's Drug Discovery Foundation 2013